Clinical trial management industry was pegged at $969.4 million in 2020, and is expected to reach $2.81 billion by 2030, growing at a CAGR of 11.2% from 2021 to 2030. Increase in industry-academic collaborations, growth in technology in the healthcare sector, rise in number of clinical trials, and increase in government support for research trials drive the growth of the global clinical trial management market. In addition, increase in awareness regarding the benefits of using CTM further and high prevalence of chronic diseases further boost the market growth. On the other hand, lack of skilled professionals and high costs associated with CTM impede the market growth. However, number of R&D activities by various pharmaceutical companies and rise in expenditure pave the way for multiple opportunities in the coming years.
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
- IBM Corporation
- PAREXEL International Corporation
- Mednet Solution Inc.
- Advarra, Inc
- Deloitte Touche Tohmatsu Limited
- Medideta Solution Inc.
- Oracle Corporation
- Veeva System Inc
- Thermo Fisher Scientific, Inc.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/2575
- The outbreak of Covid-19 negatively affected the global clinical trial management market. The focus on discovering a different COVID-19 vaccination and treatment has disrupted the upcoming and ongoing clinical studies for various diseases all across the world.
- According to the Journal of the International Nepal Epidemiological Association, 69 percent of respondents were unable to undertake ongoing clinical trials during the COVID-19 pandemic in 2020.
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/2575
By type, the enterprise-based segment accounted for nearly three-fifths of the global clinical trial management market share in 2020, and is anticipated to retain its dominance throughout the forecast period. This is owing to advancements in technology in the healthcare sector and initiatives of organizations to develop the healthcare sector. The site-based segment, however, would showcase the fastest CAGR of 12.1% by 2030. This is attributed due to increase in prevalence of chronic diseases, rise in adoption of new technologies in clinical trials, and increase in demand for site-based clinical trial management systems.
By delivery mode, the web-based segment contributed to nearly two-thirds of the global clinical trial management market revenue in 2020, and is projected to maintain the lion’s share from 2021 to 2030. This is attributed to increase in demand for web-based CTMS and increase in number of clinical trials. At the same time, the cloud-based segment would cite the fastest CAGR of 13.2% by the end of 2030, owing to advancements in technology in the healthcare sector and surge in adoption of a cloud-based system. The report also includes an analysis of on-premise segment.
By geography, North America garnered the major share in 2020, contributing to nearly half of the global clinical trial management market, and is expected to dominate the market during the forecast period. This is because of rise in prevalence of chronic diseases, increase in presence of key players to develop advanced software, and development in R&D activities in the healthcare sector in the region. Simultaneously, the Asia-Pacific region would manifest the fastest CAGR of 13.4% throughout the estimated period. This is attributed to increase in funds from government and private organizations to support clinical trials and increase in number of clinical trials.
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060